+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 - 2027

  • ID: 4330259
  • Report
  • June 2020
  • Region: Global
  • 110 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 21st Century Medicine
  • AbbVie Inc.
  • Biolife Solutions
  • Medtronic
  • Novartis
  • Stryker Corporation
  • MORE
Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 25.8 billion by 2027, growing at a CAGR of 9.3%. Growing cases of organ failure have resulted increased demand for transplantation procedures. Rising demand for tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market growth during forecast period. Thus, many biotechnology and medical device manufacturing companies are concentrating on the development of advanced transplant products.

Technological advancement in organ transplantation methods is another key factor supporting the market growth. Introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports market growth.

Transplantation Market Report Highlights
  • Tissue products was the largest revenue-generating segment due to rising demand for tissue and organ transplant procedures
  • Tissue products segment is expected to expand further at a significant CAGR owing to advancement in transplantation products
  • The transplant centers end-use segment is projected to register the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
  • The hospitals segment led the market in 2019, in terms of revenue, owing to a large number of transplant procedures performed in hospitals
  • North America was the leading regional market in 2019 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
  • Moreover, presence of a large number of research laboratories, biotechnology, and medical devices manufacturing companies in North America is projected to contribute to the region’s growth

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 21st Century Medicine
  • AbbVie Inc.
  • Biolife Solutions
  • Medtronic
  • Novartis
  • Stryker Corporation
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product type
1.1.2. Application type
1.1.3. End use
1.1.4. Region scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Transplantation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of organ failure
3.4.1.2. Technological advancement in transplantation method
3.4.1.3. Developed tissue banks
3.4.2. Market restraint analysis
3.4.2.1. Shortage of organ donors
3.4.2.2. Ethical and cultural issues
3.4.3. Key opportunities prioritized
3.4.3.1. Key opportunities prioritized, by Product
3.4.3.2. Key opportunities prioritized, by application
3.4.3.3. Key opportunities prioritized, by end use
3.5. Transplantation Market Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies

Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Tissue products
4.1.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.1.2. Immunosuppressive drugs
4.1.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
4.1.3. Preservation Solutions
4.1.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Organ transplant
5.1.2. Tissue transplant
5.2. Product Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Transplantation Market by Application Type Outlook
5.4.1. Organ transplant
5.4.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
5.4.2. Tissue transplant
5.4.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 6. Transplantation Market: End Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Transplantation centers
6.1.3. Others
6.2. Product Market Share, 2019 & 2027
6.3. Segment Dashboard
6.4. Global Transplantation Market by End Use Channel Outlook
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.4.2. Transplantation centers
6.4.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 7. Transplantation Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2019 & 2027
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2019
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.10. Latin America
7.10.1. market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (Revenue, USD Million)
7.11.3. Saudi Arabia
7.11.3.1. South Africa market estimates and forecast, 2016 - 2027 (Revenue, USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2019
8.3.4. Stryker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Procedure benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Procedure benchmarking
8.3.5.4. Strategic initiatives
8.3.6. AbbVie Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Procedure benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Zimmer Biomet
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Procedure benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Novartis
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Procedure benchmarking
8.3.8.4. Strategic initiatives
8.3.9. 21st Century Medicine
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Procedure benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biolife Solutions
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Procedure benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Teva Pharmaceutical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Procedure benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Veloxis Pharmaceuticals
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Procedure benchmarking
8.3.12.4. Strategic initiatives

Note: Product cover images may vary from those shown
3 of 3
  • Stryker Corporation
  • Medtronic
  • AbbVie Inc.
  • Zimmer Biomet
  • Novartis
  • 21st Century Medicine
  • Biolife Solutions
  • Teva Pharmaceutical
  • Veloxis Pharmaceuticals
Note: Product cover images may vary from those shown
Adroll
adroll